Joseph L. Goulet

Joseph L. Goulet

Auto-generated profile, based on publicly available information

Joseph L. Goulet

Yale School of Medicine

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1998 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
KMKathleen R. Merikangas
Kathleen R. Merikangas
MSMarilyn Stolar
Marilyn Stolar
DSDenise E. Stevens
Denise E. Stevens
JGJoseph Goulet
Joseph Goulet
MPMartin Preisig
Martin Preisig
BRBruce J. Rounsaville
Bruce J. Rounsaville
THE FAMILIAL aggregation of alcoholism has been well established.1,2 Although the results of numerous studies suggest that drug abuse is familial, there is a lack of adequate evidence from studies that use contemporary family study methods, including comparable control probands and direct interviews of relatives, in investigating the familial patterns of drug abuse.3-14

1 February 2011 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
KCKristina Crothers
Kristina Crothers
LHLaurence Huang
Laurence Huang
JGJoseph L. Goulet
Joseph L. Goulet
MGMatthew Bidwell Goetz
Matthew Bidwell Goetz
SBSheldon T. Brown
Sheldon T. Brown
AJAmy C. Justice
Amy C. Justice
Rationale: In aging HIV-infected populations comorbid diseases are important determinants of morbidity and mortality. Pulmonary diseases have not been systematically assessed in the combination antiretroviral therapy (ART) era. Objectives: To determine the incidence of pulmonary diseases in HIV-infected persons compared with HIV-uninfected persons. Methods: We analyzed data from the Veterans Aging Cohort Study Virtual Cohort, consisting of 33,420 HIV-infected veterans and 66,840 age, sex, race and ethnicity, and site-matched HIV-uninfected veterans. Using Poisson regression, incidence rates and adjusted incidence rate ratios were calculated to determine the association of HIV with pulmonary disease. The Virtual Cohort was merged with the 1999 Veterans Large Health Survey to adjust for self-reported smoking in a nested sample (14%). Measurements and Main Results: Incident chronic obstructive pulmonary disease, lung cancer, pulmonary hypertension, and pulmonary fibrosis, as well as pulmonary infections, were significantly more likely among HIV-infected patients compared with uninfected patients in adjusted analyses, although rates of asthma did not differ by HIV status. Bacterial pneumonia and chronic obstructive pulmonary disease were the two most common incident pulmonary diseases, whereas opportunistic pneumonias were less common. Absolute rates of most pulmonary diseases increased with age, although the relative differences between those with and without HIV infection were greatest in younger persons. Chronic obstructive pulmonary disease and asthma, as well as pulmonary infections, were less likely in those with lower HIV RNA levels and use of ART at baseline. Conclusions: Pulmonary diseases among HIV-infected patients receiving care within the Veterans Affairs Healthcare System in the combination ART era reflect a substantial burden of non–AIDS-defining and chronic conditions, many of which are associated with aging.

1 June 1994 in Psychiatry Research
Verified
Journal Article
Open access
MBMorris D. Bell
Morris D. Bell
PLPaul H. Lysaker
Paul H. Lysaker
JBJoseph L. Beam-Goulet
Joseph L. Beam-Goulet
RMRobert M. Milstein
Robert M. Milstein
JLJean-Pierre Lindenmayer
Jean-Pierre Lindenmayer
A five-component model of schizophrenia has been presented by Kay and Sevy based upon an analysis of the Positive and Negative Syndrome Scale. Kay and Sevy found factorial validity for negative and positive syndromes, and they identified excitement, depressive, and cognitive components as well. They suggested that subtypes and syndromes can be mapped along dimensions presented in their model. The present study compares the five-component solution for a new sample of 146 subjects to a reanalysis of the Kay and Sevy data. Despite divergent demographic characteristics, the two samples produce similar dimensions. Correlations of component loadings and subject scores as well as confirmatory factor analysis are presented. Discussion focuses on points of agreement and important differences in the symptoms assigned to each component. How the dimensions relate to rationally derived models of positive and negative syndromes is reviewed, and implications for subtyping and other methods of examining the heterogeneity of schizophrenia are considered.

1 August 2006 in Medical Care
Verified
Journal Article
Closed access
AJAmy C. Justice
Amy C. Justice
EDElizabeth Mba Dombrowski
Elizabeth Mba Dombrowski
JCJoseph Conigliaro
Joseph Conigliaro
SFShawn L. Fultz
Shawn L. Fultz
DGDeborah Ma Gibson
Deborah Ma Gibson
KBKendall Bryant
Kendall Bryant
Background: The Veterans Aging Cohort Study (VACS) is a study of human immunodeficiency virus (HIV) infected and uninfected patients seen in infectious disease and general medical clinics. VACS includes the earlier 3 and 5 site studies (VACS 3 and VACS 5) as well as the ongoing 8 site study. Objectives: We sought to provide background and context for analyses based upon VACS data, including study design and rationale as well as its basic protocol and the baseline characteristics of the enrolled sample. Research Design: We undertook a prospectively consented multisite observational study of veterans in care with and without HIV infection. Measures: Data were derived from patient and provider self report, telephone interviews, blood and DNA samples, focus groups, and full access to the national VA “paperless” electronic medical record system. Results: More than 7200 veterans have been enrolled in at least one of the studies. The 8 site study (VACS) has enrolled 2979 HIV-infected and 3019 HIV-uninfected age–race–site matched comparators and has achieved stratified enrollment targets for race/ethnicity and age and 99% of its total target enrollment as of October 30, 2005. Participants in VACS are similar to other veterans receiving care within the VA. VACS participants are older and more predominantly black than those reported by the Centers for Disease Control. Conclusions: VACS has assembled a rich, in-depth, and representative sample of veterans in care with and without HIV infection to conduct longitudinal analyses of questions concerning the association between alcohol use and related comorbid and AIDS-defining conditions.

15 December 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JGJoseph L. Goulet
Joseph L. Goulet
SFShawn L. Fultz
Shawn L. Fultz
DRDavid Rimland
David Rimland
ABAdeel Butt
Adeel Butt
CGCynthia Gibert
Cynthia Gibert
AJAmy C. Justice
Amy C. Justice
Patterns of comorbidity among persons with human immunodeficiency virus (HIV) are not well described. We compared comorbidity among veterans with and

16 February 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JWJulie A. Womack
Julie A. Womack
JGJoseph L. Goulet
Joseph L. Goulet
CGCynthia Gibert
Cynthia Gibert
CBCynthia Brandt
Cynthia Brandt
CCChung Chou Chang
Chung Chou Chang
FTfor the Veterans Aging Cohort Study Project Team
for the Veterans Aging Cohort Study Project Team
HIV infection has been associated with an increased risk of fragility fracture. We explored whether or not this increased risk persisted in HIV infected and uninfected men when controlling for traditional fragility fracture risk factors. Cox regression models were used to assess the association of HIV infection with the risk for incident hip, vertebral, or upper arm fracture in male Veterans enrolled in the Veterans Aging Cohort Study Virtual Cohort (VACS-VC). We calculated adjusted hazard ratios comparing HIV status and controlling for demographics and other established risk factors. The sample consisted of 119,318 men, 33% of whom were HIV infected (34% aged 50 years or older at baseline, and 55% black or Hispanic). Median body mass index (BMI) was lower in HIV infected compared with uninfected men (25 vs. 28 kg/m2; p<0.0001). Unadjusted risk for fracture was higher among HIV infected compared with uninfected men [HR: 1.32 (95% CI: 1.20, 1.47)]. After adjusting for demographics, comorbid disease, smoking and alcohol abuse, HIV infection remained associated with an increased fracture risk [HR: 1.24 (95% CI: 1.11, 1.39)]. However, adjusting for BMI attenuated this association [HR: 1.10 (95% CI: 0.97, 1.25)]. The only HIV-specific factor associated with fragility fracture was current protease inhibitor use [HR: 1.41 (95% CI: 1.16, 1.70)]. HIV infection is associated with fragility fracture risk. This risk is attenuated by BMI.